Labcorp Holdings Inc. (LH): who owns it and who trades it
As of Nov 16, 2026, LH insiders reported 22 open-market sales worth $11.7M and no purchases in the last 12 months, with 58% of the sale value made under pre-set 10b5-1 plans. The largest seller was Adam H Schechter (CEO), with $6.9M. 5 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Labcorp
From the latest filingsOverall: more selling than buying. Insiders and Congress mostly sold. Famous investors mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns LH
1,043 funds and institutions reported LH shares worth $22.4B at the end of Q2 2026, about 98% of the company. The largest holder is BlackRock, Inc. with 8.0%.
Funds and institutions (13F) 98%Everyone else 2%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 6.57M | 8.02% | $1.8B | +2% |
| Vanguard Capital Management LLC | 5.36M | 6.54% | $1.5B | -0% |
| Victory Capital Management Inc | 4.84M | 5.90% | $1.4B | +5% |
| State Street Corp | 3.91M | 4.77% | $1.1B | +1% |
| Vanguard Portfolio Management LLC | 3.68M | 4.49% | $1B | -0% |
| Boston Partners | 3.05M | 3.72% | $854M | +29% |
| Allspring Global Investments Holdings, LLC | 2.24M | 2.73% | $635M | +0% |
| Geode Capital Management, LLC | 2.19M | 2.67% | $610M | +0% |
| Select Equity Group, L.P. | 1.98M | 2.42% | $555M | -9% |
| FMR LLC (Fidelity) | 1.90M | 2.32% | $533M | +48% |
| Morgan Stanley | 1.61M | 1.96% | $451M | +7% |
| Dimensional Fund Advisors LP | 1.37M | 1.67% | $383M | +3% |
| JPMorgan Chase & Co | 1.27M | 1.55% | $355M | – |
| Invesco Ltd. | 1.24M | 1.51% | $347M | -6% |
| Nordea Investment Management AB | 915,939 | 1.12% | $255M | -12% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 887,431 | 1.08% | $248M | -1% |
| Northern Trust Corp | 883,076 | 1.08% | $247M | -11% |
| Wellington Management Group LLP | 855,596 | 1.04% | $240M | -11% |
| American Century Companies Inc | 845,023 | 1.03% | $237M | +4% |
| Bank of America Corp | 812,270 | 0.99% | $227M | +12% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, LH insiders reported $0 of open-market purchases and $11.7M of sales. 58% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 10, 2026 | Brian J Caveney | Vice president | Sale | 2,000 | $372.04 | $744K | Form 4 |
| Nov 3, 2026 | Bryan T Vaughn | Vice president | Sale plan | 306 | $353.70 | $108K | Form 4 |
| Oct 30, 2026 | Richelle P Parham | Director | Sale | 1,078 | $361.22 | $389K | Form 4 |
| Aug 17, 2026 | Kerrii B Anderson | Director | Sale plan | 3,000 | $318.02 | $954K | Form 4 |
| Aug 11, 2026 | Adam H Schechter | CEO | Sale plan | 4,669 | $320.37 | $1.5M | Form 4 |
| Aug 4, 2026 | Amy B. Summy | Vice president | Sale | 924 | $306.74 | $283K | Form 4 |
| Aug 3, 2026 | Peter J Wilkinson | Vice president | Sale | 1,338 | $309.23 | $414K | Form 4 |
| Aug 3, 2026 | Peter J Wilkinson | Vice president | Sale | 82 | $309.22 | $25.4K | Form 4 |
| Jul 2, 2026 | Kathryn W Kyle | Vice president | Sale plan | 92 | $286.19 | $26.3K | Form 4 |
| Jul 2, 2026 | Bryan T Vaughn | Vice president | Sale plan | 234 | $286.19 | $67K | Form 4 |
| Jun 8, 2026 | Kathryn W Kyle | Vice president | Sale plan | 762 | $263.89 | $201K | Form 4 |
| May 11, 2026 | Adam H Schechter | CEO | Sale plan | 5,903 | $254.50 | $1.5M | Form 4 |
| Mar 27, 2026 | Peter J Wilkinson | Vice president | Sale plan | 1,633 | $267.05 | $436K | Form 4 |
| Mar 27, 2026 | Jonathan C Meltzer | Vice president | Sale plan | 839 | $267.05 | $224K | Form 4 |
| Mar 3, 2026 | Adam H Schechter | CEO | Sale | 8,705 | $279.96 | $2.4M | Form 4 |
| Feb 27, 2026 | der Vaart Sandra D van | Vice president | Sale | 548 | $284.91 | $156K | Form 4 |
| Feb 24, 2026 | Brian J Caveney | Vice president | Sale | 1,500 | $286.31 | $429K | Form 4 |
| Feb 19, 2026 | Peter J Wilkinson | Vice president | Sale plan | 666 | $277.94 | $185K | Form 4 |
| Feb 12, 2026 | Jonathan C Meltzer | Vice president | Sale plan | 87 | $290.42 | $25.3K | Form 4 |
| Feb 11, 2026 | Adam H Schechter | CEO | Sale plan | 5,273 | $284.38 | $1.5M | Form 4 |
| Feb 10, 2026 | Jonathan C Meltzer | Vice president | Sale plan | 91 | $276.79 | $25.2K | Form 4 |
| Feb 9, 2026 | Jonathan C Meltzer | Vice president | Sale plan | 88 | $275.53 | $24.2K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Adam H Schechter | President & CEO, Director | – | $6.9M | Aug 11, 2026 |
| Brian J Caveney | EVP, Pres of ED, CMO & CSO | – | $1.2M | Nov 10, 2026 |
| Peter J Wilkinson | SVP, Chief Accounting Officer | – | $1.1M | Aug 3, 2026 |
| Kerrii B Anderson | Director | – | $954K | Aug 17, 2026 |
| Richelle P Parham | Director | – | $389K | Oct 30, 2026 |
| Jonathan C Meltzer | EVP, Operations | – | $299K | Mar 27, 2026 |
| Amy B. Summy | EVP, Chief Marketing Officer | – | $283K | Aug 4, 2026 |
| Kathryn W Kyle | EVP, Chief Legal Officer | – | $227K | Jul 2, 2026 |
| Bryan T Vaughn | EVP and President, Diagnostics | – | $175K | Nov 3, 2026 |
| der Vaart Sandra D van | EVP, Corporate Affairs | – | $156K | Feb 27, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
LH short interest
Low short interest. 3.1% of LH shares are sold short: about 1 share in 32. Over the last 12 reports the number of shares short went down 24%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 2.54M LH shares were sold short, 3.1% of the shares outstanding, down 0.5% from the report before. At the average daily volume of 846,259 shares, buying them all back would take about 3.0 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 2.54M | 3.13% | -1% | 846,259 | 3.0 |
| Oct 15, 2026 | 2.56M | 3.15% | -5% | 606,767 | 4.2 |
| Sep 30, 2026 | 2.68M | 3.31% | +10% | 892,507 | 3.0 |
| Sep 15, 2026 | 2.45M | 3.02% | +16% | 740,750 | 3.3 |
| Aug 31, 2026 | 2.10M | 2.59% | +9% | 660,410 | 3.2 |
| Aug 14, 2026 | 1.94M | 2.39% | -7% | 505,328 | 3.8 |
| Jul 31, 2026 | 2.09M | 2.55% | -23% | 959,198 | 2.2 |
| Jul 15, 2026 | 2.72M | 3.32% | -4% | 575,165 | 4.7 |
| Jun 30, 2026 | 2.83M | 3.45% | -13% | 743,863 | 3.8 |
| Jun 15, 2026 | 3.26M | 3.98% | -5% | 544,798 | 6.0 |
| May 29, 2026 | 3.43M | 4.18% | +2% | 588,520 | 5.8 |
| May 15, 2026 | 3.37M | 4.11% | +7% | 718,250 | 4.7 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Members of Congress who traded LH
Since Nov 17, 2024, 4 members of Congress reported 14 purchases and 6 sales of LH. The latest was a sale by April McClain Delaney on Aug 25, 2026, reported Sep 9, 2026.
Purchases 14Sales 6
Reported trades
| Trade date | Member | Type | Amount | Owner | Reported | Source |
|---|---|---|---|---|---|---|
| Aug 25, 2026 | April McClain Delaney (D-MD) | Sale | $100K–$250K | Child | Sep 9, 2026 | Report |
| Aug 7, 2026 | April McClain Delaney (D-MD) | Partial sale | $1K–$15K | Child | Sep 9, 2026 | Report |
| Aug 6, 2026 | April McClain Delaney (D-MD) | Partial sale | $1K–$15K | Child | Sep 9, 2026 | Report |
| Aug 5, 2026 | April McClain Delaney (D-MD) | Partial sale | $1K–$15K | Child | Sep 9, 2026 | Report |
| Mar 27, 2026 | Alan Armstrong (R-OK) | Purchase | $1K–$15K | Self | Jul 21, 2026 | Report |
| Feb 11, 2026 | April McClain Delaney (D-MD) | Purchase | $1K–$15K | Child | Mar 10, 2026 | Report |
| Feb 4, 2026 | April McClain Delaney (D-MD) | Purchase | $1K–$15K | Child | Mar 10, 2026 | Report |
| Jan 28, 2026 | April McClain Delaney (D-MD) | Purchase | $1K–$15K | Child | Feb 2, 2026 | Report |
| Nov 17, 2025 | April McClain Delaney (D-MD) | Purchase | $1K–$15K | Child | Dec 8, 2025 | Report |
| Oct 31, 2025 | April McClain Delaney (D-MD) | Purchase | $1K–$15K | Child | Nov 4, 2025 | Report |
| Oct 29, 2025 | April McClain Delaney (D-MD) | Purchase | $1K–$15K | Child | Nov 4, 2025 | Report |
| May 15, 2025 | Robert P. Bresnahan, Jr. (R-PA) | Purchase | $1K–$15K | Self | May 31, 2025 | Report |
| Apr 8, 2025 | Robert P. Bresnahan, Jr. (R-PA) | Sale | $1K–$15K | Self | May 8, 2025 | Report |
| Mar 31, 2025 | Gilbert Ray Cisneros, Jr. (D-CA) | Partial sale | $1K–$15K | Self | Apr 7, 2025 | Report |
| Feb 28, 2025 | April McClain Delaney (D-MD) | Purchase | $1K–$15K | Child | Mar 20, 2025 | Report |
| Feb 27, 2025 | April McClain Delaney (D-MD) | Purchase | $1K–$15K | Child | Mar 20, 2025 | Report |
| Feb 25, 2025 | Robert P. Bresnahan, Jr. (R-PA) | Purchase | $1K–$15K | Self | Mar 27, 2025 | Report |
| Feb 17, 2025 | April McClain Delaney (D-MD) | Purchase | $1K–$15K | Child | Mar 20, 2025 | Report |
| Feb 8, 2025 | April McClain Delaney (D-MD) | Purchase | $1K–$15K | Child | Mar 20, 2025 | Report |
| Feb 5, 2025 | April McClain Delaney (D-MD) | Purchase | $1K–$15K | Child | Mar 20, 2025 | Report |
Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work
Labcorp company events
Labcorp filed 27 reports on Form 8-K in the last 12 months, 5 of them about an important change (leadership). The latest was on Nov 4, 2026.
- Nov 4, 2026AnnouncementShared information with investors. Filing
- Oct 28, 2026ResultsReleased financial results. Filing
- Oct 21, 2026AnnouncementShared information with investors. Filing
- Sep 30, 2026AnnouncementShared information with investors. Filing
- Sep 22, 2026AnnouncementShared information with investors. Filing
- Sep 10, 2026AnnouncementShared information with investors. Filing
- Aug 28, 2026AnnouncementShared information with investors. Filing
- Aug 17, 2026AnnouncementShared information with investors. Filing
- Aug 14, 2026LeadershipMegan D. Bailey notified Labcorp Holdings Inc. of her decision to resign as Executive Vice President and President, Central Laboratories and International of the Company, effective September 4, 2026. Filing
- Jul 30, 2026ResultsReleased financial results. Filing
- Jul 10, 2026AnnouncementShared information with investors. Filing
- Jun 30, 2026AnnouncementShared information with investors. Filing
- May 27, 2026AnnouncementShared information with investors. Filing
- May 26, 2026VoteReported shareholder vote results. Filing
- Apr 30, 2026ResultsReleased financial results. Filing
- Apr 9, 2026AnnouncementShared information with investors. Filing
- Mar 31, 2026AnnouncementShared information with investors. Filing
- Mar 20, 2026AgreementLabcorp Holdings Inc., as parent guarantor, and Laboratory Corporation of America Holdings, as borrower, entered into a Term Loan Credit Agreement with Wells Fargo Bank, National Association, as administrative agent, Wells Fargo Securities, LLC, as joint lead arranger and sole bookrunner, PNC… Filing
- Feb 17, 2026ResultsReleased financial results. Filing
- Feb 9, 2026LeadershipLabcorp Holdings Inc. today announced that on February 6, 2026, the Company’s Board of Directors appointed John H. Sampson, M.D., Ph.D., as a member of the Board, effective February 9, 2026. Filing
- Jan 29, 2026AgreementLabcorp Holdings Inc. amended its receivables purchase agreement (as amended, the “Receivables Purchase Agreement”) by entering into the Second Amendment to the Receivables Purchase Agreement, among Labcorp Receivables LLC, Laboratory Corporation of America Holdings, PNC Bank, National Association… Filing
- Jan 15, 2026AnnouncementShared information with investors. Filing
- Jan 14, 2026AnnouncementShared information with investors. Filing
- Dec 30, 2025AnnouncementShared information with investors. Filing
- Dec 15, 2025LeadershipMark Schroeder, the Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer of Labcorp Holdings Inc., notified the Company of his intention to retire, effective on April 1, 2026. Filing
- Dec 10, 2025LeadershipDr. D. Gary Gilliland notified the Board of Directors of Labcorp Holdings Inc. of his decision to retire from the Board, effective December 31, 2025. Filing
- Nov 24, 2025LeadershipLabcorp Holdings Inc. today announced that on November 20, 2025, the Company’s Board of Directors appointed Victor Bulto as a member of the Board, effective December 1, 2025. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Labcorp financials
Famous investors that hold LH
5 of the 50 well-known investors we track reported holding LH in their latest 13F filing. The largest position is Ken Griffin's, worth $81.8M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Griffin · Citadel Advisors | Q3 2026 | 265,420 | $81.8M | 0.0% | +650% |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 74,626 | $23M | 0.1% | New |
| Israel Englander · Millennium Management | Q3 2026 | 59,429 | $18.3M | 0.0% | -74% |
| Ray Dalio · Bridgewater Associates | Q3 2026 | 2,654 | $818K | 0.0% | -5% |
| Ken Fisher · Fisher Asset Management | Q3 2026 | 1,556 | $480K | 0.0% | +20% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Labcorp Holdings Inc. (LH) stock
Who owns the most LH stock?
The largest reported owner of Labcorp Holdings Inc. (LH) is BlackRock, Inc., with 8.0% of the company. In total, 1,043 funds and institutions reported holding LH at the end of Q2 2026, together about 98% of the shares. See the largest owners.
Are LH insiders buying or selling?
In the last 12 months, LH insiders reported no open-market purchases and 22 sales worth $11.7M. The latest trade was on Nov 10, 2026. See every trade.
What is the short interest in LH?
As of Oct 30, 2026, 2.54M LH shares were sold short, 3.1% of the shares outstanding, down 0.5% from the report before. At the average daily volume of 846,259 shares, buying them all back would take about 3.0 trading days (days to cover). See the history.
Have members of Congress traded LH?
Yes. 4 members of Congress reported 14 purchases and 6 sales of LH since Nov 17, 2024. The latest was reported on Sep 9, 2026. See the trades.
Which famous investors hold LH?
5 of the 50 well-known investors we track reported LH in their latest 13F filing, including Ken Griffin, Paul Tudor Jones, Israel Englander. The largest position is worth $81.8M. See all holders.
Executive pay
Labcorp's chief executive was paid a total of $18.3M for the year ended Dec 31, 2025, down 5% from $19.3M the year before. In the last 12 months, Labcorp's executives and directors bought no stock on the open market and sold $11.7M.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.